Biogen Idec (BIIB) Approaches New Upside Target of $309.65
August 25, 2015 at 11:27 AM EDT
Biogen Idec (NASDAQ:BIIB) has opened bullishly above the pivot of $279.50 today and has reached the first level of resistance at $294.00. Investors may be interested in a cross...
